| 4EBP1 | 4E-binding protein 1 |
| 5-HT | Serotonin |
| AD | Alzheimer’s disease |
| ASD | Autism spectrum disorder |
| BBB | Blood–brain barrier |
| BCAAs | Branched-chain amino acids |
| BCAT | Branched-chain amino acid aminotransferase |
| BCKAs | Branched-chain α-keto acids |
| BCKDH | Branched-chain α-keto acid dehydrogenase complex |
| BCKDK | Branched-chain ketoacid dehydrogenase kinase |
| BMI | Body mass index |
| CNS | Central nervous system |
| CSF | Cerebrospinal fluid |
| DA | Dopamine |
| DALYs | Disability-adjusted life years |
| EMT | Epithelial–mesenchymal transition |
| FMT | Fecal microbiota transplantation |
| GABA | Gamma-aminobutyric acid |
| GBA | Gut–brain axis |
| GC-MS | Gas chromatography mass spectrometry |
| GI | Gastrointestinal |
| GWAS | Genome-wide association studies |
| HPLC-FLD | High-performance liquid chromatography |
| ILE | Isoleucine |
| KIC | α-ketoisocaproate |
| KIV | α-ketoisovalerate |
| KMV | α-keto-β-methylvalerate |
| L-dopa | Levodopa |
| LAT1 | L-type amino acid transporter 1 |
| LC-MS | Liquid chromatography-mass spectrometry |
| LEU | Leucine |
| LID | Levodopa-induced dyskinesia |
| LPS | Lipopolysaccharide |
| MCI | Mild cognitive impairment |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| MSA | Multiple system atrophy |
| MSUD | Maple Syrup Urine Disease |
| NMDA | N-methyl-D-aspartate |
| PD | Parkinson’s disease |
| PPM1K | Protein phosphatase, Mg2+/Mn2+ dependent 1K |
| PSP | Progressive supranuclear palsy |
| RBD | REM sleep behavior disorder |
| REM | Rapid eye movement |
| ROS | Reactive oxygen species |
| S6K | S6 kinase |
| SCFAs | Short-chain fatty acids |
| SNP | Single-nucleotide polymorphism |
| T2DM | Type 2 diabetes mellitus |
| TCA | Tricarboxylic acid |
| TRP | Tryptophan |
| TYR | Tyrosine |
| VAL | Valine |
| mTORC1 | Mechanistic target of rapamycin complex 1 |